We are initiating coverage on Rocket Pharmaceuticals with a Buy rating and a $17 price target (2-3 years). The company has an enterprise value, EV, of $151M at present, a valuation that implied near ...

The Board has declared an interim dividend of $0.10 per share, payable in cash. The dividend is payable on January 13, 2026, to shareholders of record as of the close of business on December 30, 2025.

AUSTIN The Railroad Commission of Texas begins the new year with the next edition of its series of virtual Listening Sessions. Taking place on Wednesday, January 14, from noon to 1:30 p.m., the ...